Drug & intervention
probenecid
RxCUI 8698
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Probenecid
Probenecid, also sold under the brand name Probalan, is a medication that increases uric acid excretion in the urine. It is primarily used in treating gout and hyperuricemia. Probenecid was developed as an alternative to caronamide to competitively inhibit renal excretion of some drugs, thereby increasing their plasma concentration and prolonging their effects.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
15 shownA Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060NCT07160738 · 2025-09-22
COMPLETEDEffects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy SubjectsNCT05497674 · 2022-02-21
COMPLETEDThe Re-Prosper HF StudyNCT04551222 · 2021-06-09
COMPLETEDA Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy SubjectsNCT03466567 · 2018-03-15
COMPLETEDStudy to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy SubjectsNCT03296800 · 2017-09-27
COMPLETEDStudy of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel FunctionNCT01320722 · 2011-03-01
COMPLETEDPrimary Prevention of Hypertension in Obese AdolescentsNCT00288158 · 2008-09-01
COMPLETEDInfluence of Probenecid and Quinine on the Pharmacokinetics of AzidothymidineNCT00000706
COMPLETEDSafety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four WeeksNCT00000670
COMPLETEDA Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) DiseaseNCT00000881
WITHDRAWNA Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS PatientsNCT00000945
COMPLETEDHPMPC (Cidofovir) Peripheral CMV Retinitis Trial ProtocolNCT00000799
COMPLETEDComparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV RetinitisNCT00000894
COMPLETEDThe Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSNCT00002437
COMPLETEDAn Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDSNCT00002142
COMPLETEDConditions being studied
HIV Infections8Cytomegalovirus Retinitis5Obesity2Type 2 Diabetes Mellitus2Blood Pressure1Cytomegalovirus Infections1Diabetes1Diabetes Mellitus, Type 21Endothelial Function1Healthy Adults1Heart Failure1Hyperuricemia1Leukoencephalopathy, Progressive Multifocal1Overweight1Pre-Hypertension1Renal Function1
Research locations
BaltimoreMaryland, United States5Chapel HillNorth Carolina, United States4BostonMassachusetts, United States3ChicagoIllinois, United States3Los AngelesCalifornia, United States3New YorkNew York, United States3San FranciscoCalifornia, United States3CincinnatiOhio, United States2RochesterNew York, United States2AtlantaGeorgia, United States1BerlinGermany1BirminghamAlabama, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.